45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
20,719
Insurances with rates
6
CPT / HCPCS codes
18,397
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9043 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $286,920 | $88,945 | — | — | 8 |
| J9228 | IPILIMUMAB 200 MG/40ML IV SOLN | $196,800 | $61,008 | — | — | 7 |
| J3357 | USTEKINUMAB 45 MG/0.5ML SC SOSY | $171,182 | $53,066 | — | — | 8 |
| J0896 | LUSPATERCEPT-AAMT 75 MG SC SOLR | $144,917 | $44,924 | — | — | 8 |
| J9281 | MITOMYCIN 80 (2 X 40) MG UL SOLR | $135,542 | $42,018 | — | — | 7 |
| J1930 | SOMATULINE DEPOT 120 MG/0.5ML SC SOLN | $112,299 | $34,813 | — | — | 7 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $112,155 | $34,768 | — | — | 8 |
| J1932 | LANREOTIDE ACETATE 120 MG/0.5ML SC SOLN | $104,438 | $32,376 | — | — | 8 |
| J9334 | EFGARTIGIMOD ALFA-HYALUR-QVFC 180-2000 MG-UNIT/ML SC SOLN | $87,419 | $27,100 | — | — | 8 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $83,797 | $25,977 | — | — | 7 |
| J0775 | COLLAGENASE CLOSTRID HISTOLYT 0.9 MG IJ SOLR | $83,479 | $25,878 | — | — | 8 |
| J0139 | ADALIMUMAB 80 MG/0.8ML SC AJKT | $81,302 | $25,204 | — | — | 15 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $68,876 | $21,352 | — | — | 7 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $65,368 | $20,264 | — | — | 8 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $62,972 | $19,521 | — | — | 8 |
| J9119 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $59,362 | $18,402 | — | — | 7 |
| J2327 | RISANKIZUMAB-RZAA 600 MG/10ML IV SOLN | $57,771 | $17,909 | — | — | 8 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $57,444 | $17,808 | — | — | 8 |
| J3380 | VEDOLIZUMAB 300 MG IV SOLR | $50,858 | $15,766 | — | — | 7 |
| J9316 | PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN | $50,410 | $15,627 | — | — | 8 |
| J9301 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $48,905 | $15,161 | — | — | 8 |
| J3101 | TENECTEPLASE 50MG IV KIT FOR PULMONARY EMBOLISM | $45,084 | $13,976 | — | — | 16 |
| J9223 | LURBINECTEDIN 4 MG IV SOLR | $44,828 | $13,897 | — | — | 7 |
| J3247 | SECUKINUMAB (300 MG DOSE) 150 MG/ML SC SOAJ | $44,812 | $13,892 | — | — | 8 |
| J9299 | NIVOLUMAB 240 MG/24ML IV SOLN | $43,160 | $13,380 | — | — | 8 |
| J1437 | FERRIC DERISOMALTOSE(ONE DOSE) 1000 MG/10ML IV SOLN | $42,893 | $13,297 | — | — | 7 |
| J9308 | RAMUCIRUMAB 500 MG/50ML IV SOLN | $40,774 | $12,640 | — | — | 7 |
| J9303 | PANITUMUMAB 400 MG/20ML IV SOLN | $39,376 | $12,207 | — | — | 8 |
| J9306 | PERTUZUMAB 420 MG/14ML IV SOLN | $37,060 | $11,489 | — | — | 8 |
| J9311 | RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN | $35,735 | $11,078 | — | — | 8 |
| J2506 | PEGFILGRASTIM INF DEV 6 MG/0.6ML SC SOSY | $34,873 | $10,811 | — | — | 8 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 160 MG IV SOLR | $34,685 | $10,752 | — | — | 8 |
| J9271 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $32,687 | $10,133 | — | — | 16 |
| J0717 | CERTOLIZUMAB PEGOL 200 MG/ML SC PSKT | $32,599 | $10,106 | — | — | 7 |
| J2802 | ROMIPLOSTIM 250 MCG SC SOLR | $32,333 | $10,023 | — | — | 8 |
| J0517 | BENRALIZUMAB 30 MG/ML SC SOSY | $31,771 | $9,849 | — | — | 8 |
| J2783 | RASBURICASE 7.5 MG IV SOLR | $30,075 | $9,323 | — | — | 16 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG IV SOLR | $27,027 | $8,378 | — | — | 7 |
| J1438 | ETANERCEPT 50 MG/ML SC SOAJ | $23,952 | $7,425 | — | — | 8 |
| J2356 | TEZEPELUMAB-EKKO 210 MG/1.91ML SC SOSY | $23,740 | $7,359 | — | — | 7 |
| 77372 | HC SRS LINEAR BASED | $23,452 | $7,270 | — | — | 8 |
| Q5111 | PEGFILGRASTIM-CBQV (INF DEV) 6 MG/0.6ML SC SOSY | $22,686 | $7,033 | — | — | 8 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 30 MG IV SOLR | $21,671 | $6,718 | — | — | 7 |
| J1568 | IMMUNE GLOBULIN HUMAN (OCTAGAM) 10% IV SOLN | $21,110 | $6,544 | — | — | 23 |
| J9061 | AMIVANTAMAB-VMJW 350 MG/7ML IV SOLN | $20,684 | $6,412 | — | — | 8 |
| J2182 | MEPOLIZUMAB 100 MG SC SOLR | $19,577 | $6,069 | — | — | 8 |
| J1306 | INCLISIRAN SODIUM 284 MG/1.5ML SC SOSY | $19,495 | $6,043 | — | — | 7 |
| Q5123 | RITUXIMAB-ARRX 500 MG/50ML IV SOLN | $19,475 | $6,037 | — | — | 7 |
| J1569 | IMMUNE GLOBULIN HUMAN (GAMMAGARD LIQUID) 10 % IJ SOLN | $18,976 | $5,883 | — | — | 38 |
| 90377 | RABIES IMMUNE GLOBULIN 1500 UNIT/10ML IJ SOLN | $18,492 | $5,733 | — | — | 8 |
Showing top 50 of 20,719 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.